Turning Complexity into Clarity with Quantum AI
We deliver quantum-powered discovery with clinical-grade security, validation, and workflow integration.
See Earlier
We surface subtle signals in imaging and multi-omics so clinicians can act before problems escalate.
Design Smarter
Simulation narrows chemical space to higher-probability candidates, accelerating R&D without cutting rigor.
Faster cycles, clearer signals. We shorten analysis time while lifting accuracy, so teams move from exploration to decisions without the guesswork.
Benchmarks are published and reproducible. Methods, cohorts, and metrics are transparent, so wins stand up to clinical and scientific scrutiny.
No re-plumbing. We meet your stack - PACS/EHR, data lakes, cloud or on-prem, with standards-based APIs and clean rollout paths.
Security is built in. PHI-safe pipelines, least-privilege access, and audit-ready logging keep governance simple and stakeholders confident.
Co-development over hand-offs. Clinicians, scientists, and engineers work shoulder-to-shoulder to fit real workflows, not ideal ones.
Long-term partnership. Clear roadmaps, dedicated support, and measurable milestones - so value compounds after day one.
Our Process
The road to validated outcomes
Impressive metrics
* Add any required disclaimer text for the claims made above using this small fine-print text.
Our people
Combining decades of experience in AI, medical imaging, clinical practice, and healthcare business development, our leadership drives innovation from quantum research to patient impact.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
Confidential Material
This section contains proprietary information intended for potential investors,
Frequently Asked Questions
How is quantum different from classical methods?
Our hybrid quantum-classical architecture explores chemical space exponentially faster. CTSim's quantum algorithms simulate millions of molecular interactions simultaneously, while classical tools process sequentially. Results: promising drug candidates identified in days versus months, with superior binding affinity predictions and early liability detection.
